Memantine for traumatic brain injury recovery
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests if adding memantine (a medication that protects brain cells) to standard care helps people recover from a mild or moderate traumatic brain injury within 24 hours of the accident.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have had a mild or moderate traumatic brain injury (based on a standard consciousness score).
- You must be able to start treatment within 24 hours of your injury.
- You cannot have serious health issues like diabetes, heart disease, kidney or liver problems, autoimmune diseases, or cancer.
- You must not be pregnant.
- You must be able to take food or medicine through a feeding tube if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if offering early support soon after a mild head injury can help reduce ongoing symptoms. If you've recently had a mild traumatic brain injury (concussion) and are still having trouble, this program might help you recover better.
This trial studies a noninvasive brain treatment (rTMS) to reduce depression symptoms in people with past mild traumatic brain injury from military service. It may help by changing brain activity, while also requiring stable mental health care and regular follow-up.
This study tests whether a combination of brain stimulation and cognitive training can reduce depression symptoms in people who have ongoing mild traumatic brain injury (TBI). It may help by targeting both mood and thinking/processing skills affected after mTBI.
This study follows older adults (65+) who had a mild traumatic brain injury (concussion) to understand how they recover over time. Researchers want to learn what helps seniors bounce back and stay active after a head injury.
This study looks at how past mild traumatic brain injury may contribute to brain changes seen in chronic traumatic encephalopathy (CTE) and Alzheimer’s disease (AD). It may help researchers understand risk and brain markers by comparing people with mild or moderate TBI, people with mild memory problems, and healthy controls.
This trial studies whether brain stimulation plus targeted brain rehabilitation can improve symptoms after a mild concussion (mTBI). You may be invited if your concussion happened at least 3 months ago and your symptoms are affecting thinking or mood, with or without PTSD.
Hear when a new Mild Traumatic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.